معرفی
Dr. Laura Humphrys is a Research Fellow in Drug Discovery Biology at the Monash Institute of Pharmaceutical Sciences, Monash University. Previously, she held a postdoctoral position at the University of Regensburg, Germany (2019–2022), focusing on peptide-based medicinal chemistry and CRISPR gene editing. She earned her PhD in Neuropharmacology from the University of Nottingham (2015–2020) and an MSci in Neuroscience from the same institution (2011–2015), with a year spent at the University of Melbourne.
Education:
- PhD in Neuropharmacology, University of Nottingham (2015–2020)
- MSci in Neuroscience, University of Nottingham (2011–2015)
Research Interests: Her work centers on visualizing and genetically modifying cell receptors in physiologically relevant cells. Key areas include GPCR biology, molecular biology, CRISPR technology, and drug discovery. She contributes to UN Sustainable Development Goals through advancements in therapeutic target identification.
Key Contributions: Laura has published extensively on topics like histamine receptor pharmacology, fluorescent ligand development, and biased agonism in GPCRs. Her research bridges basic science and translational medicine, with a focus on understudied receptors.
Awards:
- British Pharmacological Society Fellow (2023)
- AJ Clark Studentship (2015)
- Nottingham UNICAS Grant (2017)
Activities & Collaboration: She actively participates in academic events, including the ASCEPT Drug Discovery Symposium (2024) and the 4GPCRnet Conference (2023). Her collaborations span institutions in Germany, Australia, and Poland, reflecting global networks in GPCR research.
Labs & Teams: Works in the labs of Prof. Denise Wootten and Prof. Patrick Sexton at Monash, focusing on metabolic receptor pharmacology. Her lab employs advanced microscopy and CRISPR tools to study receptor dynamics in live cells.
